FindMyKOL
Clinical trialNCT02403895TerminatedPhase 2Interventional

AZD2014 and Weekly Paclitaxel in Squamous NSCLC

SponsorAstraZenecaEnrollment11Squamous Non Small Cell Lung Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Open--label, phase 2a, multi-centre, single-arm study to assess the efficacy and safety of AZD2014 and weekly paclitaxel in patients with squamous non-small cell lung cancer (NSCLC)

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Germany
  • Research Site

    Gauting, Germany

Spain
  • Research Site

    Barcelona, Spain

  • Research Site

    Girona, Spain

United States
  • Research Site

    Boston, Massachusetts, United States

  • Research Site

    Detroit, Michigan, United States

  • Research Site

    Hershey, Pennsylvania, United States

  • Research Site

    Dallas, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Open-label AZD2014Paclitaxel →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
15 Apr 2015
Primary completion
29 Dec 2016
Completion
29 Dec 2016
Last update posted
3 Jul 2018
Registered enrollment
11
Registry id
NCT02403895

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.